EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Commercial Strategy and Financial Planning in the American Pharmaceutical Industry: Market Access, Drug Pricing and Revenue Growth
A winning American pharma commercial strategy treats pricing payer access and financial planning as one system Companies that model net price not list price early build evidence for payers before launch and plan cash flow around rebates patient assistance and policy risk grow revenue more predictably than those that treat these as separate workstreams
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
Identification of flavonoids from natural products against hyperlipidaemia through computational approaches
Over the centuries hyperlipidaemia has been recognised as a major risk factor contributing to cardiovascular disease CVD Current research increasingly explores natural compounds such as flavonoids for their potential lipidlowering effects This study evaluated pharmacological potential
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Navigating Healthcare Precision: Therapeutic Drug Monitoring in Treatment
Kate Williamson
Therapeutic Drug Monitoring (TDM) is pivotal in precision healthcare, ensuring optimal drug levels for effective treatment while minimizing side effects. This article explores TDM's significance i...
-
2
-
3
How Smart Factories Are Transforming the Future of Pharmaceutical Manufacturing
Lakshmi
Smart factories, which connect equipment, data and people through sensors, automation, analytics and artificial intelligence, are moving from pilot projects to the core of US pharmaceutical operations...
-
4
Enhancing Patient Care with Digital Tools in the Pharmaceutical Sector
Kate Williamson
Digital tools are proliferating productive millennium patients care in the global pharmaceutical Industry by widening access, liabilities, and tailored therapy. Using such technologies as mobile appli...
-
5
Personalized Medicine and Genomics: Charting a New Course in Drug Innovation
Kate Williamson
These are personalized medicine, which can be attributed to the enhancements in genomics as treatment procedures that are formulated according to people’s genetic make-up offers enhanced efficac...
press releasesRead more...
Argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities
Argenx the immunology innovation company today announced a definitive agreement to acquire Unnatural Products Inc UNP adding a macrocyclic peptide discovery engine to its immunology innovation capabilities argenx which already holds a minority stake in UNP will acquire all remaining shares in a tran...
PharmaLogic to Acquire Lantheus' CDMO Business and Springfield, New Jersey Manufacturing Facility
PharmaLogic Holdings Corp the only independent contract development and manufacturing organization CDMO of scale dedicated exclusively to radiopharmaceuticals today announced a definitive agreement to acquire the CDMO business and Springfield New Jersey manufacturing facility from Lantheus Holdings...
Sino Biological Advances AI-Designed Molecule Validation with 4RISETM
AI can generate protein candidates at an unprecedented speed but experimental validation remains essential to determine whether they properly express bind targets and demonstrate the desired biological properties Sino Biological Inc Shenzhen Stock Exchange SZ a global leader in recombinant protein t...
CareValidate Launches First Same-Day Prescription Delivery for Telehealth Brands, Starting with GLP-1 Treatments in Houston
CareValidate the compliance and clinical infrastructure behind some of the fastestgrowing telehealth brands in the country is launching sameday prescription delivery in Houston Telehealth businesses on the CareValidate platform can now offer eligible patients home delivery within hours instead of wa...
Events Read more...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
10 - 11
Nov 2026Extractables & Leachables Europe
Parkhotel Schӧnbrunn, Vienna,...
10 - 12
Nov 2026Lab Asset & Facility Management Summit
The Westin Boston Seaport Dist...
11 - 13
Nov 2026Frontiers in Cancer Science 2026
One Farrer Hotel,1 Farrer Park...
11 - 12
Nov 2026Medical Device Project and Portfolio Management
Chicago, IL, USA
16 - 17
Nov 2026Analytics for Smarter Decisions in Pharma
London, UK
24 - 25
Nov 2026BioPharma Deals - The Survival Series
Munich, Germany
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
LATEST NEWSRead more...
PharmAla Biotech Signs Supply and Data Agreement with Aalborg University Hospital for Danish Randomized Trial of MDMA-Assisted Treatment for Service-Related PTSD
PharmAla Biotech Holdings Inc a biotechnology company focused on the research development and manufacturing of MDXXclass molecules including its proprietary LaNeo MDMA announces that it has signed a Project Supply Agreement the Agreement with the North Denmark Region
PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product
PharmAla Biotech Holdings Inc a biotechnology company focused on the research development and manufacturing of MDXXclass molecules including its proprietary LaNeo MDMA announces that it has signed an agreement with Corealis Pharma Inc Corealis a GMPcompliant contract development
Thermo Fisher Scientific Introduces Value-Priced Thermo Scientific™ AmpSure™ Universal qPCR Master Mixes Without Compromising Performance
Thermo Fisher Scientific the world leader in serving science today introduces the Thermo Scientific AmpSure Universal SYBR Green and Probe Master Mixes Designed for everyday applications the mixes support reliable reproducible quantitative PCR qPCR performance and offer researchers a valuepriced opt...
Polaris Rx Selected by Bristol Myers Squibb to Dispense ZENBEXUS™ (iberdomide), the First FDA-Approved CELMoD Therapy for Multiple Myeloma
Polaris Rx announced today that it has been selected by Bristol Myers Squibb to dispense ZENBEXUS iberdomide the first cereblon E ligase modulator CELMoD therapy approved by the US Food and Drug Administration FDA ZENBEXUS is approved in combination with daratumumab
Moleculent Introduces Glimt, the First Automated Instrument for Functional Profiling of Cell-Cell Interactions in Human Tissue
Moleculent AB the life sciences technology company pioneering functional profiling today announced Glimt an automated platform that detects cellcell interactions directly in formalinfixed paraffinembedded FFPE tissue The Glimt platform is now available to selected academic
Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement
Rhythm Pharmaceuticals Inc announced an amendment to the global exclusive license agreement with LG Chem Ltd for bivamelagon an investigational oral smallmolecule melanocortin receptor MCR agonist The Company also announced a fiveyear term loan facility led by KKR
